BNTX BioNTech SE
Healthcare$92.25+0.12%ClosedMarket Cap: $23.33B
As of 2026-05-26
Institutional Ownership Summary
Investors Holding
317
13F Shares
47,892,972
Ownership %
20.0%
New Positions
63
Increased Positions
146
Closed Positions
39
Reduced Positions
80
ETF Exposure
| ETF Symbol | ETF Name | Shares Held | Weight % |
|---|---|---|---|
| Global X - Genomics & Biotechnology ETF | 18,367 | 3.93% | |
| iShares Genomics Immunology and Healthcare ETF | 57,088 | 3.37% | |
| VanEck Biotech ETF | 90,077 | 2.17% | |
| ARK Genomic Revolution ETF | 121,880 | 1.02% | |
| 2,191,720 | 0.81% | ||
| 2,191,720 | 0.81% | ||
| iShares Biotechnology ETF | 600,193 | 0.66% | |
| Invesco NASDAQ Next Gen 100 ETF | 51,161 | 0.54% | |
| T. Rowe Price Capital Appreciation Equity ETF | 282,533 | 0.40% | |
| State Street SPDR S&P Kensho New Economies Composite ETF | 30,681 | 0.12% | |
| Invesco RAFI Developed Markets ex-U.S. ETF | 24,301 | 0.08% | |
| Schwab Fundamental International Large Company Index ETF | 193,852 | 0.08% | |
| Fidelity Contrafund | 1,093,586 | 0.07% | |
| 19,918 | 0.05% | ||
| Fidelity Nasdaq Composite Index ETF | 27,959 | 0.03% | |
| State Street SPDR Portfolio Developed World ex-US ETF | 96,445 | 0.02% | |
| First Trust NYSE Arca Biotechnology Index Fund | 818,432 | 0.00% |